Physician profile
Michael Morcos
NPI 1710623061
$1,777.65
in general payments reported to CMS, 2019-2025
7 companies · $1,778 in 2025
The $1,778 reported for 2025 was more than what 89% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,777.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $701.66 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $370.48 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Stryker Corporation | $239.71 | 2025 | Prostep Mica, Augment Injectable |
| Extremity Medical | $146.87 | 2025 | |
| Trilliant Surgical LLC. | $132.02 | 2025 | Arsenal Sinus Support Plate |
| Paratek Pharmaceuticals, INC. | $125.00 | 2025 | Nuzyra |
| Linvatec Corporation | $61.91 | 2025 | 5ms, Biobrace 23mm, Fracture and Correction Colag 2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Morcos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.